Jaundice Caused by Liver Cancer: How to Book a Professional Consultation Service on StrongBody AI
Jaundice is a clinical symptom that results in the yellowing of the skin and the whites of the eyes. It occurs when there is an excessive buildup of bilirubin—a yellow pigment formed by the breakdown of red blood cells—in the bloodstream. This condition signals problems with the liver, gallbladder, or bile ducts, and in severe cases, it may indicate malignancy.
People with jaundice often experience additional symptoms such as dark-colored urine, pale stools, itching, fatigue, and abdominal discomfort. Although jaundice can be triggered by various conditions, one of the most serious causes is Liver Cancer. In such cases, jaundice reflects impaired liver function or bile duct obstruction due to tumor growth.
Jaundice caused by liver cancer is more than a symptom—it’s a potential warning sign of disease progression. This makes timely medical evaluation and expert consultation essential for early detection and treatment planning.
Liver cancer, particularly hepatocellular carcinoma (HCC), originates in liver cells and often leads to structural and functional liver damage. It is a leading cause of cancer mortality worldwide, with hundreds of thousands of cases diagnosed annually.
Primary causes of liver cancer include:
- Chronic hepatitis B or C infection
- Cirrhosis from alcohol abuse or non-alcoholic fatty liver disease
- Genetic liver disorders
- Exposure to aflatoxins and other toxins
Jaundice in liver cancer occurs because tumors block bile ducts or impair the liver’s ability to process and excrete bilirubin. This symptom can be one of the first visible indicators, especially in advanced stages of the disease.
Other symptoms of liver cancer include weight loss, fatigue, abdominal swelling, nausea, and loss of appetite. If jaundice appears in combination with any of these, immediate medical attention is critical.
Managing jaundice due to liver cancer involves both treating the underlying malignancy and relieving the obstructive symptoms. Treatment options include:
- Tumor Resection or Liver Transplantation: For eligible patients, surgery may remove the cancer and restore liver function.
- Biliary Stents or Drainage: In cases where tumors obstruct the bile ducts, stents or drainage tubes can be inserted to allow bile flow and reduce jaundice.
- Chemotherapy and Immunotherapy: Systemic cancer treatments may help reduce tumor burden and improve liver function.
- Supportive Therapy: Includes anti-itch medications, hydration, and dietary support to manage secondary symptoms and improve quality of life.
The success of treatment depends heavily on early diagnosis and specialist-led care, highlighting the importance of accessing a professional consultation service for jaundice.
A specialized consultation service for jaundice enables patients to receive expert guidance on diagnosing the cause, understanding test results, and exploring personalized treatment options.
Consultation services typically include:
- Comprehensive symptom assessment and medical history review
- Recommendation for diagnostic tests: liver function panels, imaging, and tumor markers
- Evaluation of treatment options tailored to cancer stage and patient condition
- Coordination with specialists such as hepatologists, oncologists, and radiologists
StrongBody AI provides global access to certified consultants who are experienced in managing complex symptoms like jaundice caused by liver cancer, with an emphasis on convenience, affordability, and patient safety.
A critical part of jaundice evaluation is imaging, which helps determine the cause and severity of the condition. One key task in StrongBody AI’s consultation service for jaundice is the virtual imaging consultation, where experts review patient scans remotely.
Step-by-step process includes:
- Image Submission: Patients upload existing scans (ultrasound, CT, or MRI).
- Expert Review: A certified radiologist or hepatologist analyzes the imaging data to identify obstructions, tumors, or liver abnormalities.
- Clinical Correlation: Findings are linked to blood test results and symptoms.
- Action Plan: Based on the review, a personalized care plan is shared, possibly including further tests, surgical referrals, or treatment recommendations.
This virtual task eliminates delays and ensures swift, accurate diagnosis from anywhere in the world.
In the autumn of 2025, during a virtual patient forum hosted by the American Liver Foundation and the European Liver Patients’ Association, one testimony from Bordeaux brought a deep, reverent quiet to thousands of viewers. The speaker was Claire Dubois, 48, a sommelier and wine educator who led tasting tours through the vineyards of Médoc, who had been living with hepatocellular carcinoma for fourteen months.
Claire’s swelling began subtly: a gentle tightness around her waist after long days walking the gravel paths between vines. Within weeks her abdomen had grown firm and rounded, clothes straining, a persistent bloating that no diuretic or restricted diet could reduce. By evening the distension pressed upward, making breathing shallow and sleep fitful; by morning fluid had shifted, leaving her legs heavy and her balance uncertain. Scans revealed ascites—fluid accumulating as the tumour impaired liver function and portal circulation—compounded by years of undetected hepatitis B. Repeated paracenteses drained litres at a time, but the fluid returned faster than before, turning every vineyard tour into a calculation of how long she could stand without discomfort becoming visible to clients.
For over a year Claire pursued every avenue. She saw renowned hepatologists at Pellegrin University Hospital and in Paris, travelled to specialised centres in Heidelberg and London, spent tens of thousands on private albumin infusions, lymphatic drainage therapy, and experimental diuretics. She tried every health app on the market—AI bloating trackers that asked for waist measurements and suggested peppermint tea, wearable fluid monitors that buzzed generic “elevated pressure” alerts, virtual symptom logs that never anticipated the rapid re-accumulation or explained why certain wines triggered worse swelling despite her abstinence. Nothing slowed the cycle. By mid-2025 she had cancelled most tours; the woman whose palate once guided connoisseurs through grand crus now struggled to bend and lift sample cases, her reflection in the tasting-room mirror increasingly unfamiliar.
One misty September evening in 2025, after a day when even loose linen dresses felt constricting, Claire joined an international liver-cancer support group on Zoom. A participant from Lisbon spoke gently about StrongBody AI—a platform that connected patients with world-class specialists who used continuous data from wearables, home blood tests, and detailed logs to anticipate and manage complications in real time. Unlike the impersonal apps she had tried, StrongBody AI paired her with a real physician who followed her body’s fluid dynamics around the clock.
With little left but determination, Claire signed up that night. She uploaded her complete medical records, connected her smart scale, wearable, the home liver-function and oncotic-pressure kit her hospital had provided, and the abdominal circumference sensor band, then described her greatest burden: the relentless abdominal swelling that was stealing her mobility, her livelihood, and her confidence in her own body. Within hours the platform matched her with Dr. Lars Nielsen, a Danish oncologist-hepatologist based in Copenhagen with twenty-six years of experience in advanced liver malignancies and a research focus on cancer-related ascites. Dr. Nielsen had pioneered remote protocols combining real-time portal-pressure estimation, inflammatory markers, and personalised diuretic timing with dietary and positional strategies to reduce fluid re-accumulation.
Their first video consultation left Claire quietly moved. Dr. Nielsen did not begin with medication adjustments. He asked about the rhythm of her tours—the hours on her feet among the vines, the pride of introducing guests to terroir, the salt-tinged Atlantic air that seemed to worsen retention. He studied the live data stream and gently explained patterns her local team had not fully connected: how inflammatory surges preceded rapid fluid shifts, how stress before large groups altered albumin levels, how subtle dietary sodium hidden in restaurant lunches triggered cascades.
Her family was deeply sceptical. Her husband, a vineyard manager, worried aloud: “We need someone who can drain the fluid here, Claire, not a doctor in Denmark we’ve never met.” Her grown son, studying oenology in California, cautioned, “Apps didn’t help before—why risk more disappointment?” Friends in the wine trade murmured about privacy and “paying for distant hope.” Claire nearly paused the subscription.
Then came a morning in October 2025 that tested everything.
Claire woke to find her abdomen painfully distended overnight, breathing laboured, legs swollen and heavy. The abdominal sensor registered critical pressure; inflammatory markers spiked, albumin dropped sharply. The StrongBody AI system detected the cascade and triggered an urgent alert. Alone—her husband away at a harvest meeting in Saint-Émilion—she opened the app with trembling fingers.
Dr. Nielsen answered within ninety seconds, calm and fully present despite the early hour. He reviewed the real-time data, asked precise questions, and guided her step by step: start the emergency diuretic boost and albumin infusion protocol they had pre-planned, elevate legs at the exact angle they had practised, use gentle lymphatic massage timed to her heart-rate variability, and take a short-acting anti-inflammatory he instantly coordinated with her Bordeaux oncologist. He stayed online until the pressure began to ease and the markers trended downward, then arranged a same-day paracentesis slot and courier delivery of supportive medication.
By afternoon the crisis had stabilised without emergency admission. Claire sat at her kitchen table overlooking the garden, tears falling—not from discomfort this time, but from the profound relief of being guided safely through a morning when breathing had felt impossible.
Trust grew swiftly after that day. Dr. Nielsen refined her regimen: micro-timed diuretics synced to her circadian data and vineyard schedule, low-sodium meal plans that still honoured French cuisine, gentle movement routines adapted for long days among vines, and stress-reduction techniques woven into the tasting experience. Monthly reviews showed fluid accumulation slowing; paracenteses became less frequent, swelling more predictable and manageable. By late 2025 Claire had resumed leading small private tours, planned a new series of intimate vineyard dinners, and even began mentoring young sommeliers again.
Mornings now started with a quiet check of the StrongBody AI dashboard: abdominal pressure steady, inflammatory markers calm, a soft green light of progress.
In her forum testimony, Claire’s voice is warm and steady: “Liver cancer tried to take away my body’s comfort and my life’s passion, but it also led me to StrongBody AI and Dr. Nielsen. For the first time I feel truly understood—my data, my vines, my days all seen together. I’m not just waiting for the next drainage anymore—I’m tasting, teaching, living.”
As the chat fills with messages of hope and quiet wonder, viewers lean closer, hearts lifted, wondering what the coming seasons will bring for Claire—and whether their own relief might be waiting just one connection away.
In the autumn of 2025, during a virtual patient forum hosted by the American Liver Foundation and the European Liver Patients’ Association, one testimony from Bordeaux brought a deep, reverent quiet to thousands of viewers. The speaker was Claire Dubois, 48, a sommelier and wine educator who led tasting tours through the vineyards of Médoc, who had been living with hepatocellular carcinoma for fourteen months.
Claire’s swelling began subtly: a gentle tightness around her waist after long days walking the gravel paths between vines. Within weeks her abdomen had grown firm and rounded, clothes straining, a persistent bloating that no diuretic or restricted diet could reduce. By evening the distension pressed upward, making breathing shallow and sleep fitful; by morning fluid had shifted, leaving her legs heavy and her balance uncertain. Scans revealed ascites—fluid accumulating as the tumour impaired liver function and portal circulation—compounded by years of undetected hepatitis B. Repeated paracenteses drained litres at a time, but the fluid returned faster than before, turning every vineyard tour into a calculation of how long she could stand without discomfort becoming visible to clients.
For over a year Claire pursued every avenue. She saw renowned hepatologists at Pellegrin University Hospital and in Paris, travelled to specialised centres in Heidelberg and London, spent tens of thousands on private albumin infusions, lymphatic drainage therapy, and experimental diuretics. She tried every health app on the market—AI bloating trackers that asked for waist measurements and suggested peppermint tea, wearable fluid monitors that buzzed generic “elevated pressure” alerts, virtual symptom logs that never anticipated the rapid re-accumulation or explained why certain wines triggered worse swelling despite her abstinence. Nothing slowed the cycle. By mid-2025 she had cancelled most tours; the woman whose palate once guided connoisseurs through grand crus now struggled to bend and lift sample cases, her reflection in the tasting-room mirror increasingly unfamiliar.
One misty September evening in 2025, after a day when even loose linen dresses felt constricting, Claire joined an international liver-cancer support group on Zoom. A participant from Lisbon spoke gently about StrongBody AI—a platform that connected patients with world-class specialists who used continuous data from wearables, home blood tests, and detailed logs to anticipate and manage complications in real time. Unlike the impersonal apps she had tried, StrongBody AI paired her with a real physician who followed her body’s fluid dynamics around the clock.
With little left but determination, Claire signed up that night. She uploaded her complete medical records, connected her smart scale, wearable, the home liver-function and oncotic-pressure kit her hospital had provided, and the abdominal circumference sensor band, then described her greatest burden: the relentless abdominal swelling that was stealing her mobility, her livelihood, and her confidence in her own body. Within hours the platform matched her with Dr. Lars Nielsen, a Danish oncologist-hepatologist based in Copenhagen with twenty-six years of experience in advanced liver malignancies and a research focus on cancer-related ascites. Dr. Nielsen had pioneered remote protocols combining real-time portal-pressure estimation, inflammatory markers, and personalised diuretic timing with dietary and positional strategies to reduce fluid re-accumulation.
Their first video consultation left Claire quietly moved. Dr. Nielsen did not begin with medication adjustments. He asked about the rhythm of her tours—the hours on her feet among the vines, the pride of introducing guests to terroir, the salt-tinged Atlantic air that seemed to worsen retention. He studied the live data stream and gently explained patterns her local team had not fully connected: how inflammatory surges preceded rapid fluid shifts, how stress before large groups altered albumin levels, how subtle dietary sodium hidden in restaurant lunches triggered cascades.
Her family was deeply sceptical. Her husband, a vineyard manager, worried aloud: “We need someone who can drain the fluid here, Claire, not a doctor in Denmark we’ve never met.” Her grown son, studying oenology in California, cautioned, “Apps didn’t help before—why risk more disappointment?” Friends in the wine trade murmured about privacy and “paying for distant hope.” Claire nearly paused the subscription.
Then came a morning in October 2025 that tested everything.
Claire woke to find her abdomen painfully distended overnight, breathing laboured, legs swollen and heavy. The abdominal sensor registered critical pressure; inflammatory markers spiked, albumin dropped sharply. The StrongBody AI system detected the cascade and triggered an urgent alert. Alone—her husband away at a harvest meeting in Saint-Émilion—she opened the app with trembling fingers.
Dr. Nielsen answered within ninety seconds, calm and fully present despite the early hour. He reviewed the real-time data, asked precise questions, and guided her step by step: start the emergency diuretic boost and albumin infusion protocol they had pre-planned, elevate legs at the exact angle they had practised, use gentle lymphatic massage timed to her heart-rate variability, and take a short-acting anti-inflammatory he instantly coordinated with her Bordeaux oncologist. He stayed online until the pressure began to ease and the markers trended downward, then arranged a same-day paracentesis slot and courier delivery of supportive medication.
By afternoon the crisis had stabilised without emergency admission. Claire sat at her kitchen table overlooking the garden, tears falling—not from discomfort this time, but from the profound relief of being guided safely through a morning when breathing had felt impossible.
Trust grew swiftly after that day. Dr. Nielsen refined her regimen: micro-timed diuretics synced to her circadian data and vineyard schedule, low-sodium meal plans that still honoured French cuisine, gentle movement routines adapted for long days among vines, and stress-reduction techniques woven into the tasting experience. Monthly reviews showed fluid accumulation slowing; paracenteses became less frequent, swelling more predictable and manageable. By late 2025 Claire had resumed leading small private tours, planned a new series of intimate vineyard dinners, and even began mentoring young sommeliers again.
Mornings now started with a quiet check of the StrongBody AI dashboard: abdominal pressure steady, inflammatory markers calm, a soft green light of progress.
In her forum testimony, Claire’s voice is warm and steady: “Liver cancer tried to take away my body’s comfort and my life’s passion, but it also led me to StrongBody AI and Dr. Nielsen. For the first time I feel truly understood—my data, my vines, my days all seen together. I’m not just waiting for the next drainage anymore—I’m tasting, teaching, living.”
As the chat fills with messages of hope and quiet wonder, viewers lean closer, hearts lifted, wondering what the coming seasons will bring for Claire—and whether their own relief might be waiting just one connection away.
In the autumn of 2025, at the European Liver Cancer Network’s annual patient symposium held virtually from Lisbon, a single video testimony brought the entire audience to a breathless pause. The woman on screen was Sofia Alvarez, a 44-year-old painter from Barcelona, Spain, whose warm olive skin and expressive hazel eyes had, over the past year, taken on a deepening yellow cast—sclera tinted like aged parchment, skin glowing unnaturally golden under studio lights, a persistent itch crawling beneath the surface. It was the unmistakable jaundice of advanced hepatocellular carcinoma (HCC), caused by tumor obstruction of bile ducts and failing liver function, turning her body into a canvas she no longer recognized or trusted.
Sofia’s life had always been color. Her small Montjuïc studio overflowed with canvases of Catalan light—ochre sunsets over the Mediterranean, emerald vines in Priorat, the deep indigo of midnight fiestas. Galleries in El Born showed her work; tourists and collectors sought her vibrant street scenes. But jaundice dulled everything. Colors she once mixed instinctively now looked wrong—yellows too harsh, greens sickly. The relentless itch kept her awake scratching until skin broke; fatigue made standing at the easel for hours impossible. Dark urine and pale stools terrified her in private. She canceled exhibitions, turned down commissions, and watched her world fade to muted tones. She spent tens of thousands of euros on hepatologists in Barcelona and Madrid, private MRIs, bile-duct stenting attempts, antipruritics, and every AI health app promising symptom tracking. Those tools delivered only cold summaries: “Elevated bilirubin—consult specialist” or “Possible liver issue—monitor diet,” never addressing the anguish of an artist losing her ability to see and trust color, or the fear that each deepening shade meant the cancer advancing silently.
Devastated by the theft of her palette and vitality, Sofia joined a Spanish-speaking liver cancer support group online. There, amid raw exchanges of scans and fears, one member quietly shared how StrongBody AI had restored not just numbers, but hope—through real human expertise watching over real-time data.
With fading light but stubborn determination, Sofia signed up in early 2025. She uploaded everything: serial bilirubin and liver enzyme charts, daily photos of her eyes and skin showing the yellow progression, itch intensity logs, sleep fractured by scratching, activity data revealing shorter studio sessions, even voice notes confessing how jaundice made her avoid mirrors and doubt every brushstroke. Within hours, the system matched her with Dr. Karl Eriksson, a hepatologist-oncologist in Helsinki with twenty-one years specializing in HCC and biliary complications. Dr. Eriksson had pioneered Nordic protocols for managing jaundice through integrated metabolic, inflammatory, and interventional data, and he was renowned for detecting subtle bilirubin shifts before crises.
Their first video consultation felt like a fresh canvas after rain. Dr. Eriksson didn’t begin with labs. He asked about her studio—the play of light on Sagrada Família spires she loved painting, how jaundice distorted her perception of cadmium yellow versus lemon, whether the itch interrupted her flow during late-night sessions. He traced correlations between bilirubin spikes and dehydration after long hours mixing oils, inflammatory surges from stress over canceled shows, and poor sleep from relentless pruritus. “Your body is overpainting itself in yellow,” he said gently. “We will help you mix the right balance again—color by color.” Sofia felt, for the first time, that someone saw the artist beneath the jaundice.
Resistance came swiftly from those closest. Her partner, Luis, a gallery curator, worried about trusting “a doctor in Finland we’ve never met in person.” Her sister urged staying with the team at Hospital Clínic: “Barcelona has world-class care—why risk an app across Europe?” Friends in the art world cautioned about costs when sales were slow. Sofia wavered, studying her yellowed reflection in the studio mirror.
But gentle, steady improvements rebuilt faith. Dr. Eriksson adjusted supportive therapies—timed ursodeoxycholic acid, anti-inflammatory protocols woven around her painting schedule, hydration reminders synced to studio time—all informed by uploaded trends. The platform’s alerts caught bilirubin rises early. Itch lessened; eyes began to clear; Sofia mixed colors with growing confidence, completing a small series that sold quickly.
The true crisis arrived one sultry September night in 2025. After a day pushing through a new commission, Sofia woke at 3 a.m. to skin burning with itch, eyes stinging, a sudden deepening yellow visible even in lamplight—bilirubin surging, nausea rising, signs of a severe obstructive flare threatening encephalopathy. Luis was away at Art Basel; the apartment silent except for her frantic scratching. Heart pounding, she opened StrongBody AI. The system instantly detected the emergency—uploaded photos showing rapid scleral change, heart-rate spike, activity plunge—and connected her to Dr. Eriksson in under a minute.
“Sofia, I’m here,” his voice calm across the continent. “I see the bilirubin climbing fast—likely tumor pressure. We’re bringing it down now.” He guided immediate relief: rescue antipruritic from her kit, hydration with electrolytes, breathing to calm autonomic response. He monitored vitals live, adjusted as levels began to respond, and arranged an urgent e-prescription for enhanced biliary support delivered to the 24-hour pharmacy near Plaça d’Espanya. He stayed until the itch dulled and confusion lifted, coordinating with her Barcelona team for morning intervention.
Sofia cried quietly when the call ended—not from despair, but from overwhelming gratitude. Someone far away had seen the warning in her colors before she fully did and guided her safely back.
In the months that followed, the yellow tide receded. Bilirubin stabilized; eyes and skin regained their warmth. Itch became occasional; energy returned in waves. Sofia reopened her studio fully, held a sold-out exhibition of new works titled “Light Returning,” and planned a residency in Tuscany she had postponed for years.
Looking back, Sofia says softly: “Liver cancer tried to repaint me in its own shade. StrongBody AI and Dr. Eriksson gave me back my true palette. I’m still on the canvas, but now I’m the one holding the brush.”
Each morning she checks her dashboard, exchanges a brief message with Dr. Eriksson, and steps to the easel with clearer eyes. The jaundice that once threatened to overwrite her has faded into background, and her story continues—one vibrant stroke, one vigilant connection, one luminous dawn at a time.
How to Book a Jaundice Consultation on StrongBody AI
StrongBody AI is a leading online platform connecting patients with healthcare specialists around the globe. Whether you're managing early symptoms or seeking a second opinion, booking a consultation for jaundice due to liver cancer is simple, fast, and secure.
Step-by-Step Booking Instructions
Step 1: Create an Account
Go to StrongBody AI and click “Sign Up.” Enter your name, country, email, occupation, and create a secure password.
Step 2: Search for a Jaundice Consultation Service
Use the search bar or navigate to the “Symptom Consultation” section. Enter “jaundice due to liver cancer” or select “Liver & Digestive Health.”
Step 3: Filter Your Preferences
Narrow your options by:
- Medical specialty (Hepatology, Oncology, Internal Medicine)
- Budget range and currency
- Language and country preference
- Format: video, audio, or message consultation
Step 4: Compare Global Experts
Review detailed profiles, which include:
- Credentials and licenses
- Years of experience
- Patient reviews and ratings
- Consultation fees and time availability
You can compare service prices worldwide to choose the most qualified consultant within your budget.
Step 5: Book Your Appointment
Choose your provider and preferred time slot. Complete payment securely through StrongBody AI’s encrypted platform.
Step 6: Attend the Consultation
Join your session at the scheduled time via StrongBody’s dashboard. Discuss your jaundice symptoms, share test results, and receive personalized medical advice.
Top 10 StrongBody AI Experts for Jaundice Consultation Due to Liver Cancer
- Dr. Martin Kwan, MD (USA) – Hepatology consultant with expertise in liver tumors
- Dr. Sayuri Yamashita, MD (Japan) – Specialist in hepatocellular carcinoma and bile duct obstruction
- Dr. Ramesh Chatterjee, MD (India) – GI oncologist and jaundice diagnosis expert
- Dr. Elisa Monti, MD (Italy) – Liver cancer diagnosis and palliative care strategist
- Dr. Ahmed Al-Taher, MD (UAE) – Expert in minimally invasive biliary procedures
- Dr. Stephanie Nguyen, MD (Canada) – Specialist in systemic therapies for liver cancer
- Dr. José Alvarez, MD (Mexico) – Hepato-oncology expert with surgical experience
- Dr. Marion Dupont, MD (France) – Radiologist focused on liver and bile duct imaging
- Dr. Thomas Müller, MD (Germany) – Liver disease management with focus on advanced jaundice
- Dr. Claire Robertson, MD (UK) – Consultant in cancer symptom relief and liver dysfunction
All these experts are available through StrongBody AI, with transparent pricing and global access to care.
Jaundice is a critical symptom, often marking the onset or progression of liver cancer. Its presence requires immediate medical evaluation and a well-informed, coordinated treatment plan. Ignoring jaundice can lead to severe complications and worsen prognosis.
By using a dedicated consultation service for jaundice on StrongBody AI, patients can access qualified specialists, receive a tailored diagnosis, and start effective treatments—all from the comfort of their homes. With tools to compare service prices worldwide and select from the top international experts, StrongBody AI offers a powerful, affordable solution for managing jaundice linked to liver cancer.
Take action early. Book your StrongBody AI consultation today and take the first step toward controlling jaundice and improving your liver health.
Overview of StrongBody AI
StrongBody AI is a platform connecting services and products in the fields of health, proactive health care, and mental health, operating at the official and sole address:https://strongbody.ai. The platform connects real doctors, real pharmacists, and real proactive health care experts (sellers) with users (buyers) worldwide, allowing sellers to provide remote/on-site consultations, online training, sell related products, post blogs to build credibility, and proactively contact potential customers via Active Message. Buyers can send requests, place orders, receive offers, and build personal care teams. The platform automatically matches based on expertise, supports payments via Stripe/Paypal (over 200 countries). With tens of millions of users from the US, UK, EU, Canada, and others, the platform generates thousands of daily requests, helping sellers reach high-income customers and buyers easily find suitable real experts. StrongBody AI is where sellers receive requests from buyers, proactively send offers, conduct direct transactions via chat, offer acceptance, and payment. This pioneering feature provides initiative and maximum convenience for both sides, suitable for real-world health care transactions – something no other platform offers.
StrongBody AI is a human connection platform, enabling users to connect with real, verified healthcare professionals who hold valid qualifications and proven professional experience from countries around the world.
All consultations and information exchanges take place directly between users and real human experts, via B-Messenger chat or third-party communication tools such as Telegram, Zoom, or phone calls.
StrongBody AI only facilitates connections, payment processing, and comparison tools; it does not interfere in consultation content, professional judgment, medical decisions, or service delivery. All healthcare-related discussions and decisions are made exclusively between users and real licensed professionals.
StrongBody AI serves tens of millions of members from the US, UK, EU, Canada, Australia, Vietnam, Brazil, India, and many other countries (including extended networks such as Ghana and Kenya). Tens of thousands of new users register daily in buyer and seller roles, forming a global network of real service providers and real users.
The platform integrates Stripe and PayPal, supporting more than 50 currencies. StrongBody AI does not store card information; all payment data is securely handled by Stripe or PayPal with OTP verification. Sellers can withdraw funds (except currency conversion fees) within 30 minutes to their real bank accounts. Platform fees are 20% for sellers and 10% for buyers (clearly displayed in service pricing).
StrongBody AI acts solely as an intermediary connection platform and does not participate in or take responsibility for consultation content, service or product quality, medical decisions, or agreements made between buyers and sellers.
All consultations, guidance, and healthcare-related decisions are carried out exclusively between buyers and real human professionals. StrongBody AI is not a medical provider and does not guarantee treatment outcomes.
For sellers:
Access high-income global customers (US, EU, etc.), increase income without marketing or technical expertise, build a personal brand, monetize spare time, and contribute professional value to global community health as real experts serving real users.
For buyers:
Access a wide selection of reputable real professionals at reasonable costs, avoid long waiting times, easily find suitable experts, benefit from secure payments, and overcome language barriers.
The term “AI” in StrongBody AI refers to the use of artificial intelligence technologies for platform optimization purposes only, including user matching, service recommendations, content support, language translation, and workflow automation.
StrongBody AI does not use artificial intelligence to provide medical diagnosis, medical advice, treatment decisions, or clinical judgment.
Artificial intelligence on the platform does not replace licensed healthcare professionals and does not participate in medical decision-making.
All healthcare-related consultations and decisions are made solely by real human professionals and users.
